Son Sang-Yong, Choi Hai-Young, Lee Yoontaek, Park Young Suk, Shin Dong Joon, Oo Aung Myint, Jung Do Hyun, Ahn Sang-Hoon, Park Do Joong, Lee Hye Seung, Kim Hyung-Ho
Department of Surgery, Ajou University Hospital, Suwon, Korea.
Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Korea.
J Gastric Cancer. 2019 Jun;19(2):173-182. doi: 10.5230/jgc.2019.19.e14. Epub 2019 Apr 19.
Intraoperative peritoneal washing cytology (PWC) is used to determine treatment strategies for gastric cancer with suspected serosal invasion. However, a standard staining method for intraoperative PWC remains to be established. We evaluated the feasibility of a rapid and simple staining method using Shorr's stain for intraoperative PWC in advanced gastric cancer.
Between November 2012 and December 2014, 77 patients with clinical T3 or higher gastric cancer were enrolled. The sensitivity, specificity, and concordance between the Shorr staining method and conventional Papanicolaou (Pap) staining with carcinoembryonic antigen (CEA) immunohistochemistry (IHC) were analyzed.
Intraoperative PWC was performed laparoscopically in 69 patients (89.6%). The average time of the procedure was 8.3 minutes, and the average amount of aspirated fluids was 83.3 mL. The average time for Shorr staining and pathologic review was 21.0 minutes. Of the 77 patients, 16 (20.7%) had positive cytology and 7 (9.1%) showed atypical findings; sensitivity and specificity were 73.6% and 98.2% for the Shorr method, and 78.9% and 98.2% for the Pap method with CEA IHC, respectively. Concordance of diagnosis between the 2 methods was observed in 90.9% of cases (weighted κ statistic=0.875) and most disagreements in diagnoses occurred in atypical findings (6/7). In overall survival, there was no significant difference in C-index between the 2 methods (0.459 in Shorr method vs. 0.458 in Pap with CEA IHC method, P=0.987).
Shorr staining could be a rapid and reliable method for intraoperative PWC in advanced gastric cancer.
术中腹腔冲洗细胞学检查(PWC)用于确定疑似浆膜侵犯的胃癌治疗策略。然而,术中PWC的标准染色方法仍有待确立。我们评估了使用肖尔氏染色法对进展期胃癌进行术中PWC的快速简便染色方法的可行性。
2012年11月至2014年12月,纳入77例临床T3期及以上胃癌患者。分析了肖尔氏染色法与传统巴氏(Pap)染色联合癌胚抗原(CEA)免疫组化(IHC)的敏感性、特异性及一致性。
69例患者(89.6%)通过腹腔镜进行术中PWC。该操作平均时间为8.3分钟,平均吸出液体量为83.3 mL。肖尔氏染色和病理检查的平均时间为21.0分钟。77例患者中,16例(20.7%)细胞学检查呈阳性,7例(9.1%)表现为非典型结果;肖尔氏染色法的敏感性和特异性分别为73.6%和98.2%,Pap染色联合CEA IHC法的敏感性和特异性分别为78.9%和98.2%。两种方法诊断的一致性在90.9%的病例中观察到(加权κ统计量 = 0.875),诊断差异大多发生在非典型结果中(6/7)。在总生存方面,两种方法的C指数无显著差异(肖尔氏染色法为0.459,Pap染色联合CEA IHC法为0.458,P = 0.987)。
肖尔氏染色可能是进展期胃癌术中PWC的一种快速可靠的方法。